Palo Capital’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-1,020
Closed -$60K 150
2015
Q2
$60K Buy
+1,020
New +$71.9K 0.05% 127

Other funds holding PTX

Palo Capital's PTX Position: Q3 2015 in Review

Palo Capital sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2015, closing a stake of 1,020 shares — an estimated $60K sold.

Palo Capital first reported a position in PTX in Q2 2015 and held it in 1 quarter. The position peaked at $60K in Q2 2015. 104 funds tracked by Wall St. Rank hold PTX as of Q3 2015.

  • Palo Capital reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2015 after selling out during the quarter.
  • Palo Capital sold 1,020 Pernix Therapeutics Holdings, Inc. shares in Q3 2015, an estimated $60K.
  • Palo Capital first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2015 and held it in 1 quarter.
  • Palo Capital's Pernix Therapeutics Holdings, Inc. position peaked at $60K in Q2 2015.
  • 104 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2015.

Based on Palo Capital's 13F filing for Q3 2015, filed 12 Nov 2015.